Why Is Relmada Therapeutics Stock Soaring Monday?

Relmada Therapeutics Inc. (NASDAQ:RLMD) shares are up during Monday’s premarket session following the release of promising interim data from its Phase 2 trial of NDV-01 for treating non-muscle invasive bladder cancer. Bladder Cancer Trial Data The 12-month interim...